References
- Martin A, Thompson AA. Thalassemias. Pediatr Clin North Am. 2013;60(6):1383–1391.
- Taher AT, Weatherall DJ, Cappellini MD. Thalassaemia. Lancet. 2018;391(10116):155–167.
- Aydinok Y. Thalassemia. Hematology. 2012;17(Suppl 1):S28–S31.
- Rund D, Rachmilewitz E. β-Thalassemia. N Engl J Med. 2005;353(11):1135–1146.
- Origa R. β-Thalassemia. Genet Med. 2017;19(6):609–619.
- World Health Organization. The World Health Organization Quality of Life assessment (WHOQOL): position paper from the World Health Organization. Soc Sci Med. 1995;41(10):1403–1409.
- Haghpanah S, Nasirabadi S, Ghaffarpasand F, et al. Quality of life among Iranian patients with β-thalassemia major using the SF-36 questionnaire. Sao Paulo Med J. 2013;131(3):166–172.
- Adib-Hajbaghery M, Ahmadi M, Poormansouri S. Health related quality of life, depression, anxiety and stress in patients with β-thalassemia major. Iran J Ped Hematol Oncol. 2015;5(4):193–205.
- Shafiee A, Nazari S, Jorjani S, et al. Prevalence of depression in patients with β-thalassemia as assessed by the Beck’s Depression Inventory. Hemoglobin. 2014;38(4):289–291.
- Koçyiğit H, Aydemir Ö, Fişek G. Kısa Form-36 (KF-36)’nın Türkçe için güvenilirliği ve geçerliliği. Romatizmal hastalığı olan bir grup hasta ile çalışma [Turkish]. İlaç ve Tedavi Dergisi. 1999;12(12):102–116.
- Durak A, Palabıyıkoğlu R. Beck Umutsuzluk ölçeğinin geçerlilik çalışması [Turkish]. Kriz Dergisi. 1994;2(2):311–319.
- Yengil E, Acipayam C, Kokacya MH, et al. Anxiety, depression and quality of life in patients with β thalassemia major and their caregivers. Int J Clin Exp Med. 2014;7(8):2165–2172.
- Tuysuz G, Tayfun F. Health-related quality of life and its predictors among transfusion-dependent thalassemia patients. J Pediatr Hematol Oncol. 2017;39(5):332–336.
- Adam S, Afifi H, Thomas M, et al. Quality of life outcomes in a pediatric thalassemia population in Egypt. Hemoglobin. 2017;41(1):16–20.
- Sobota A, Yamashita R, Xu Y, et al.; Thalassemia Clinical Research Network. Quality of life in thalassemia: a comparison of SF-36 results from the thalassemia longitudinal cohort to reported literature and the US norms. Am J Hematol. 2011;86(1):92–95.
- Khoury B, Musallam KM, Abi-Habib R, et al. Prevalence of depression and anxiety in adult patients with β-thalassemia major and intermedia. Int J Psychiatry Med. 2012;44(4):291–303.
- Hakeem GLA, Mousa SO, Moustafa AN, et al. Health-related quality of life in pediatric and adolescent patients with transfusion-dependent β-thalassemia in upper Egypt (single center study). Health Qual Life Outcomes. 2018;16(1):59–68.